Option Care Health (OPCH) is under legal scrutiny after Kirby McInerney LLP launched an investigation into alleged securities law violations following weaker first quarter 2026 results and a reduced full year revenue outlook.

The share price reaction has been sharp, with a 1 month share price return down 26.30% and a 3 month share price return down 42.01%, while the 5 year total shareholder return remains positive at 14.12%. This suggests recent momentum has weakened against a longer term gain.

If recent volatility in Option Care Health has you reassessing your exposure to healthcare, it can help to widen your watchlist and review 34 healthcare AI stocks

With the stock down sharply over 1 year and trading at a discount to both an analyst price target and some intrinsic value estimates, the key question is simple: is this a reset that creates opportunity, or is the market already accounting for future growth?

Most Popular Narrative: 31.9% Undervalued

At a last close of $20.93 versus a widely followed fair value of about $30.73, the current price sits well below the narrative valuation, which is built on detailed assumptions about earnings, margins, and future cash flows using a 6.98% discount rate.

Growth in both acute and chronic infusion therapies is outpacing the market, driven by demographic shifts (aging population and higher prevalence of chronic/complex conditions), which is expanding Option Care Health's addressable market and positioning the company for sustained revenue growth.

Want to see what kind of revenue curve and margin profile would justify that higher fair value? The narrative leans heavily on compounding earnings power, a richer therapy mix, and a future earnings multiple that assumes investors keep paying up for this cash flow profile. Curious which specific growth and profitability levers carry the most weight in that model?

Result: Fair Value of $30.73 (UNDERVALUED)

However, you also need to weigh risks such as tighter reimbursement terms and a shift toward lower margin therapies, which could challenge the bullish earnings narrative.

Next Steps

With mixed sentiment around Option Care Health, now is a good time to move quickly, review the data, and decide where you stand on its 3 key rewards and 1 important warning sign

Looking for more investment ideas?

Do not stop with one stock. Use this moment to expand your watchlist, compare different types of opportunities, and give yourself more options for your next move.

• Target higher yields by scanning for companies that combine income potential with resilience through the 10 dividend fortresses.
• Spot potential mispricings by focusing on companies with solid fundamentals that the market may be overlooking via the screener containing 21 high quality undiscovered gems.
• Prioritise stability by filtering for companies that pair financial strength with healthy balance sheets using the solid balance sheet and fundamentals stocks screener (46 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.